6. パーキンソン病 Parkinson disease Clinical trials / Disease details
臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04228172 (ClinicalTrials.gov) | February 24, 2020 | 7/1/2020 | Genotypic Influences on Network Progression in Parkinson's Disease | Genotypic Influences on Network Progression in Parkinson's Disease | Parkinson's Disease | Genetic: DNA/GeneticTesting;Radiation: FDG PET scan;Other: MRI scan;Other: Clinical and neuropsychological assessments | Northwell Health | Michael J. Fox Foundation for Parkinson's Research;The Silverstein Foundation for Parkinson's with GBA | Recruiting | 40 Years | 75 Years | All | 32 | United States |